Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03842228 |
| Title | Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Colorado Hospital | Suspended | Aurora | Colorado | 80045 | United States | Details |
| Brigham and Women's Hospital | Recruiting | Boston | Massachusetts | 02115 | United States | Details |
| Beth Israel Deaconess Medical Center | Suspended | Boston | Massachusetts | 02215 | United States | Details |
| Dana-Farber Cancer Institute | Recruiting | Boston | Massachusetts | 02215 | United States | Details |
| University of Texas at Austin | Recruiting | Austin | Texas | 78712 | United States | Details |
| University of Texas Medical Branch | Recruiting | Galveston | Texas | 77555-0565 | United States | Details |
| M D Anderson Cancer Center | Recruiting | Houston | Texas | 77030 | United States | Details |
| University of Texas Health Science Center at San Antonio | Suspended | San Antonio | Texas | 78229 | United States | Details |